Skip to main content
×
×
Home

Clozapine and blood dyscrasia

  • Zahid Latif (a1), Faraz Jabbar (a2) and Brendan D. Kelly (a2)
Summary

Clozapine is an effective antipsychotic medication but is associated with agranulocytosis, neutropenia and leucopenia. The reintroduction of clozapine improved management of treatment-resistant schizophrenia, yet resulted in a paradoxical situation whereby the risk of blood dyscrasias is rigorously managed but other adverse effects (e.g. seizures, cardiovascular complications) are less well monitored. Monitoring of weight, lipids, plasma glucose and other metabolic parameters is recommended. There is also a need to reconsider routine haematological monitoring with other medications associated with blood dyscrasia (e.g. phenothiazines, carbamazepine). In particular, individuals who develop clozapine-induced blood dyscrasia may require haematological monitoring during treatment with other antipsychotics.

Copyright
Corresponding author
Zahid Latif (drzahidlatif@gmail.com)
Footnotes
Hide All

Declaration of interest

None.

Footnotes
References
Hide All
1 Crilly, J. The history of clozapine and its emergence in the US market: a review and analysis. Hist Psychiatry 2009; 18;3960.
2 Kane, J, Honigfeld, G, Singer, J, Meltzer, H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789–96.
3 Pirmohamed, M, Park, K. Mechanism of clozapine-induced agranulocytosis. CNS Drugs 1997; 7: 139158.
4 Gerson, SL. Clozapine – deciphering the risks. N Engl J Med 1993; 329: 204–5.
5 Gerson, SL. G-CSF and the management of clozapine-induced agranulocytosis. J Clin Psychiatry 1994; 55: 139–42.
6 Atkin, K, Kendall, F, Gould, D, Freeman, H, Lieberman, J, O'Sullivan, D. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996; 169: 483–8.
7 Dunk, LR, Annan, LJ, Andrews, CD. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy. Br J Psychiatry 2006; 188: 255–63.
8 Munro, J, O'Sullivan, D, Andrews, C, Arana, A, Mortimer, A, Kerwin, R. Active monitoring of 12760 clozapine recipients in the UK and Ireland: beyond pharmacovigilance. Br J Psychiatry 1999; 175: 576–80.
9 Kelly, DL, Kreyenbuhl, J, Dixon, L, Love, RC, Medoff, D, Conley, RR. Clozapine underutilization and discontinuation in African Americans due to leucopenia. Schizophr Bull 2007; 33: 1221–4.
10 Williams, DP, Pirmohamed, M, Naisbitt, DJ, Maggs, JL, Park, BK. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis. J Pharmacol Exp Ther 1997; 283: 1375–82.
11 Sackett, DL, Rosenberg, WM, Gray, JA, Haynes, RB, Richardson, WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71–2.
12 Esposito, D, Hardy, P, Corruble, E. Clozapine treatment following blood dyscrasia. Br J Psychiatry 2006; 189: 186.
13 Ghaznavi, S, Nakic, M, Rao, P, Hu, J, Brewer, JA, Hannestad, J, Bhagwagar, Z. Rechallenge with clozapine following neutropenia: treatment options for refractory schizophrenia. Am J Psychiatry 2008; 165: 813–8.
14 Taylor, D, Paton, C, Kapur, S. The South London and Maudsley NHS Foundation Trust and Oxleas NHS Foundation Trust Prescribing Guidelines (10th edn). Informa Healthcare, 2009.
15 Whiskey, E, Taylor, D. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities. CNS Drugs 2007; 21: 2535.
16 Dernovsek, Z, Tavcar, R. Risperidone induced leucopenia and neutropenia. Br J Psychiatry 1997; 171: 393–4.
17 Thangadurai, P, Jyothi, KS, Gopalakrishnan, R, Kuruvilla, A, Jacob, KS. Reversible neutropenia with olanzapine following clozapine-induced neutropenia. Am J Psychiatry 2006; 163: 1298.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 1758-3209
  • EISSN: 1758-3217
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 14 *
Loading metrics...

Abstract views

Total abstract views: 110 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 21st June 2018. This data will be updated every 24 hours.

Clozapine and blood dyscrasia

  • Zahid Latif (a1), Faraz Jabbar (a2) and Brendan D. Kelly (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *